Literature DB >> 9987468

Universal HIV screening at a major metropolitan TB clinic: HIV prevalence and high-risk behaviors among TB patients.

S E Weis1, B Foresman, P E Cook, K J Matty.   

Abstract

OBJECTIVES: This study assessed the outcome of implementing a policy of universal screening of patients with tuberculosis (TB) for HIV infection at a major metropolitan public health TB clinic.
METHODS: HIV serologic testing was completed on 768 (93%) of 825 eligible patients. Ninety-eight HIV-positive cases (13%) were compared with 670 HIV-negative cases. The presence of adult HIV risk factors was determined by structured interview and review of medical records.
RESULTS: One or more HIV risk factors were present in 93% of HIV-positive cases and 42% of HIV-negative cases.
CONCLUSIONS: The metropolitan TB clinic is well suited for HIV screening, and HIV-antibody testing and counseling should be provided to all TB patients.

Entities:  

Mesh:

Year:  1999        PMID: 9987468      PMCID: PMC1508514          DOI: 10.2105/ajph.89.1.73

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  11 in total

Review 1.  Tuberculosis in patients with human immunodeficiency virus infection.

Authors:  P F Barnes; A B Bloch; P T Davidson; D E Snider
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

2.  HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDS.

Authors:  R W Shafer; K D Chirgwin; A E Glatt; M A Dahdouh; S H Landesman; B Suster
Journal:  AIDS       Date:  1991-04       Impact factor: 4.177

3.  Prevalence of human immunodeficiency virus infection among patients attending tuberculosis clinics in the United States.

Authors:  I M Onorato; E McCray
Journal:  J Infect Dis       Date:  1992-01       Impact factor: 5.226

4.  Human immunodeficiency virus and hepatitis B virus infections in a New York City alcoholic population.

Authors:  J M Jacobson; T M Worner; H S Sacks; C S Lieber
Journal:  J Stud Alcohol       Date:  1992-01

5.  HIV testing in patients with tuberculosis. Physician response to national recommendations.

Authors:  D J Katz; W N Hall; N B Keon; L R Crane
Journal:  Am Rev Respir Dis       Date:  1993-05

6.  HIV infection and risk behaviors among heterosexuals in alcohol treatment programs.

Authors:  A L Avins; W J Woods; C P Lindan; E S Hudes; W Clark; S B Hulley
Journal:  JAMA       Date:  1994-02-16       Impact factor: 56.272

7.  HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample.

Authors:  A R Zolopa; J A Hahn; R Gorter; J Miranda; D Wlodarczyk; J Peterson; L Pilote; A R Moss
Journal:  JAMA       Date:  1994-08-10       Impact factor: 56.272

8.  Human immunodeficiency virus infection in tuberculosis patients.

Authors:  C P Theuer; P C Hopewell; D Elias; G F Schecter; G W Rutherford; R E Chaisson
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

9.  Testing for human immunodeficiency virus infection in patients with tuberculosis.

Authors:  P F Barnes; C Silva; M Otaya
Journal:  Am J Respir Crit Care Med       Date:  1996-04       Impact factor: 21.405

10.  Human T-cell lymphotropic virus-III (HTLV-III) seropositivity and related disease among 71 consecutive patients in whom tuberculosis was diagnosed. A prospective study.

Authors:  A E Pitchenik; J Burr; M Suarez; D Fertel; G Gonzalez; C Moas
Journal:  Am Rev Respir Dis       Date:  1987-04
View more
  3 in total

1.  HIV/TB co-infection in mainland China: a meta-analysis.

Authors:  Lei Gao; Feng Zhou; Xiangwei Li; Qi Jin
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

2.  Assessing missed opportunities for HIV testing in medical settings.

Authors:  Rebecca V Liddicoat; Nicholas J Horton; Renata Urban; Elizabeth Maier; Demian Christiansen; Jeffrey H Samet
Journal:  J Gen Intern Med       Date:  2004-04       Impact factor: 5.128

3.  Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants.

Authors:  Travis C Porco; Bryan Lewis; Elliot Marseille; Jennifer Grinsdale; Jennifer M Flood; Sarah E Royce
Journal:  BMC Public Health       Date:  2006-06-19       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.